氯胺酮
医学
科克伦图书馆
儿科
荟萃分析
癫痫持续状态
置信区间
回顾性队列研究
系统回顾
人口
随机对照试验
梅德林
队列研究
队列
子群分析
麻醉
癫痫
内科学
精神科
环境卫生
政治学
法学
作者
Nicolas Chiriboga,Thomas Spentzas,Renad Abu‐Sawwa
出处
期刊:Epilepsia
[Wiley]
日期:2024-06-17
卷期号:65 (8): 2200-2212
被引量:6
摘要
Abstract Objective Status epilepticus (SE) is a common neurological medical emergency in the pediatric population, with 10%–40% of cases progressing to refractory SE (RSE), requiring treatment with anesthetic infusions. We present a systematic review and meta‐analysis of the use of ketamine for the treatment of pediatric SE and its potential advantages over other anesthetic infusions. Methods This review follows the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) statement. Electronic databases, including PubMed, Cochrane Library, Ovid, Embase, and Google Scholar, were searched with the keywords “pediatrics,” “status epilepticus,” and “ketamine treatment.” Randomized trials, prospective and retrospective cohort studies, and case reports were considered for inclusion. Results Eighteen publications met the initial inclusion criteria. The 18 publications comprise 11 case reports, one nonconclusive clinical trial, two case series, and four retrospective cohorts. After excluding the case reports because of reporting bias, only the six case series and cohorts were included in the final analysis. There were 172 patients in the six included studies. The weighted age was 9.93 (SD = 10.29) years. The weighted maximum dose was 7.44 (SD = 9.39) mg/kg/h. SE cessation was attained in 51% (95% confidence interval = 43–59) of cases with the addition of ketamine. The heterogeneity was I 2 = 0%, t 2 = 0, χ 2 (5) = 3.39 ( p = .64). Significance Pediatric RSE is difficult to treat, resulting in increased morbidity and mortality. Without strong recommendations and evidence regarding preferred agents, this review provides evidence that ketamine may be considered in managing SE in the pediatric population.
科研通智能强力驱动
Strongly Powered by AbleSci AI